Drugs / Molsidomine
last change Sep 2014 re-read 9 days ago

Molsidomine

Small molecule

Developed for
myocardial ischemia
Investigated by
Luzerner Kantonsspital · Therabel Pharma SA/NV

Trials 2

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial · 1 missed
Phase 4 NCT01363661 Jun 2011 → Sep 2014 atherosclerosis Therabel Pharma SA/NV Completed Missed primary
Phase not applicable1 trial
— NCT00382421 Feb 1992 → Apr 2006 myocardial ischemia Luzerner Kantonsspital Completed No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Molsidomine “Molsidomine 16 mg tablet, per os, once a day” NCT01363661 ↗
1

NCT00382421 ↗

Known as CAS 276 ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455 ↗
Known as Coruno “Coruno (molsidomine 16 mg tablet; per os; once daily)” NCT01363661 ↗
Known as Corvasal ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455 ↗
Known as Corvaton mite ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455 ↗
Known as Corvaton ret ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455 ↗
Known as Molsidomina ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455 ↗
Known as Morsydomine ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455 ↗
Known as NSC-757398 ChEMBL registry synonym — accepted as the source's own label CHEMBL1329455 ↗
Modality Small molecule — CHEMBL1329455 ↗
Route Oral “Molsidomine 16 mg tablet, per os, once a day” NCT01363661 ↗